Raltitrexed in Treating Children With Refractory Acute Leukemia
NCT00003528
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
NIH
Sponsor class
Conditions
Recurrent Childhood Acute Lymphoblastic Leukemia
Recurrent Childhood Acute Myeloid Leukemia
Interventions
DRUG:
raltitrexed
Sponsor
National Cancer Institute (NCI)